<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=iso-8859-1"><meta name=Generator content="Microsoft Word 14 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0cm;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";
        mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
span.EstiloDeEmail17
        {mso-style-type:personal-compose;
        font-family:"Calibri","sans-serif";
        color:windowtext;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-family:"Calibri","sans-serif";
        mso-fareast-language:EN-US;}
@page WordSection1
        {size:612.0pt 792.0pt;
        margin:70.85pt 3.0cm 70.85pt 3.0cm;}
div.WordSection1
        {page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=PT-BR link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:14.0pt'>Dear Marco Tulio and Kleber and colleagues<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:14.0pt'> Regarding the work of Soto with miltefosine, 2007, I believe that this has serious methodological errors, such opinions are published on this Article - Mucosal leishmaniasis and miltefosine Tuon FF, Amato VS Clin Infect Dis. 2007 Jun 1, 44 (11) :1525-6; author reply 1526-7. I suggest that a patient would be possibility for this low-dose liposomal amphotericin as 2mg/kg.Por longer time than usual.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:14.0pt'> Best regards<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:14.0pt'> Valdir Amato<o:p></o:p></span></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span style='mso-fareast-language:PT-BR'>_____________________________________________<o:p></o:p></span></p><p class=MsoNormal><span style='mso-fareast-language:PT-BR'>Prof. Dr. Valdir Sabbaga Amato<o:p></o:p></span></p><p class=MsoNormal><span style='mso-fareast-language:PT-BR'>Médico Supervisor da Clínica de Moléstias Infecciosas e Parasitárias do HC-FMUSP<o:p></o:p></span></p><p class=MsoNormal><span style='mso-fareast-language:PT-BR'>Responsável pelo Ambulatório de leishmanioses da Clínica de Moléstias Infecciosas e Parasitárias do HC-FMUSP </span><span style='font-size:12.0pt;mso-fareast-language:PT-BR'><o:p></o:p></span></p><p class=MsoNormal><span style='mso-fareast-language:PT-BR'>Orientador de Mestrado e Doutorado<o:p></o:p></span></p><p class=MsoNormal><o:p> </o:p></p></div></body></html>